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Purpose: This study investigates the inflammation in the anterior chamber in eyes with primary angle closure glaucoma
(PACG) and evaluates the effect of intraocular pressure (IOP) elevation on the blood-aqueous barrier (BAB).
Methods: Thirty-five patients (35 eyes) with acute primary angle closure glaucoma (APACG), 42 patients (42 eyes) with
chronic primary angle closure glaucoma (CPACG), and 50 age-matched healthy controls (50 eyes) were included in this
study. The flare value and cell counts were quantified using laser flare cell photometry. Statistical analysis was performed
to compare differences in flare value and cell counts between different groups and explore the relation between the
inflammation and IOP.
Results: The mean flare value (photon counts per millisecond, ph/ms) in the APACG, CPACG, and healthy control group
was 141.4±123.1, 7.7±4.1, and 4.5±1.1, respectively. The mean cell counts (cells/0.5 mm3) in the three groups were
126.0±67.8, 5.2±5.8, and 0.8±0.7, respectively. The flare value and cell counts in both the APACG group and the CPACG
group were significantly higher than those in the healthy control group (p<0.001). Furthermore, the flare value and cell
counts in the APACG group were significantly  higher  than those in  the CPACG group (p<0.001). There were positive
correlations between the IOP level and flare value (r=0.527, p<0.001), and cell counts(r=0.775, p<0.001), respectively, in
the APACG group.
Conclusions: Disrupted BAB and inflammation in the anterior chamber were found in eyes with both kinds of PACG.
The damage of BAB was more severe in eyes with APACG than those with CPACG. The IOP elevation, especially a
dramatic IOP elevation, might be the factor responsible for the change of BAB in eyes with PACG.
Primary  angle  closure  glaucoma  (PACG)  is  the  most
common type of glaucoma in the Asian population, and it is
responsible for most of bilateral glaucoma blindness in China
[1].  As  a  common  complex  disease,  it  has  become  an
important target for association studies in recent years [2].
Several  previous  studies  focusing  on  the  pathogenesis  of
PACG  have  suggested  that  the  geometry  of  the  anterior
chamber [3], certain genes [4-7], and several other risk factors
[8] are related with PACG. Yet, the pathological change in
PACG has not been clearly investigated. The alteration of the
blood-aqueous barrier (BAB), which is located in the apico-
lateral surfaces of the non-pigmented epithelium of the ciliary
body and between the endothelial cells of the iris vasculature
[9], has been unknown. The BAB shows a high degree of
selectivity that prevents the passage of plasma proteins into
the aqueous humor, which helps to keep a very low protein
concentration and rare cells of aqueous humor to maintain
optical clarity and prevent light scattering. It was reported that
the control of the barrier function is influenced by the flow of
aqueous humor in the routes between Schlemm's canal and the
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anterior chamber [10]. Since PACG always has an elevation
of intraocular pressure (IOP) resulting from the abnormality
in the aqueous humor dynamics, it seems that the BAB may
be affected in eyes with PACG.
Aqueous flare and cells are generally considered to be
two  inflammatory  parameters  of  anterior  chamber
inflammation resulting from destruction of the BAB. Despite
various  characteristic  clinical  signs  such  as  conjunctival
congestion, corneal epithelial edema, middilated unreactive
pupil,  glaucomflecken,  and  iris  atrophy,  tyndallometry  is
frequently observed in eyes with acute primary angle closure
glaucoma (APACG) soon after an attack episode during the
slit-lamp biomicroscopy examination. Because the slit-lamp
biomicroscopy examination is qualitative and subjective with
considerable intra- and inter-observer variations, there has
been no quantitative data referring to the anterior chamber
inflammation in eyes with APACG. On the other hand, the
aqueous flare and cells are rarely seen in eyes with chronic
primary angle closure glaucoma (CPACG) in the slit-lamp
biomicroscopy examination. Previously, there has been no
published data on the change of the BAB in eyes with CPACG.
Laser flare cell photometry (LFCM) represents the first
noninvasive,  objective,  and  quantitative  method  to  assess
intraocular  inflammation  [11].  It also  allows  the  accurate
detection of subclinical alterations in the BAB [11]. With the
application of laser flare cell photometry, the changes of the
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2026BAB have been studied in a variety of ocular diseases such as
uveitis [12-14] and noninflammatory diseases [15-17]. Laser
flare cell photometry also shows utility in the comparison of
the effects on the BAB of different surgical techniques [18,
19],  surgical  adjuncts  [20],  laser  procedures  [21,22],  and
several  new  medical  managements  of  glaucoma  [23,24].
However, laser flare photometry has not yet been applied to
study the change of the BAB in eyes with PACG. Neither has
the effect of IOP elevation on the permeability of the BAB
been investigated.
In this study, we used laser flare cell photometry for
aqueous flare and cells measurements to both quantitatively
evaluate the inflammation in the anterior chamber in eyes with
PACG and explore the influence of IOP elevation on the BAB.
METHODS
The study was conducted at Zhongshan Ophthalmic center of
Sun Yat-sen University, Guangzhou, People’s Republic of
China from 1 October 2008 to 30 September 2009 with the
approval  of  the  Ethics  Committees  of  the  Zhongshan
Ophthalmic Center and in accordance with the tenets of the
Declaration of Helsinki. All patients and healthy volunteers
were  informed  about  the  nature  of  the  noninvasive
examinations  of  LFCM.  Informed  written  consents  were
obtained.
The study comprised three groups of participants: the
APACG  group,  the  CPACG  group,  and  the  age-matched
healthy control group. The diagnostic criteria of the APACG
group were the following: 1) the presence of at least two of
the following symptoms: eye pain, headache, blurred vision,
and vomiting; 2) the presence of at least three of the following
signs:  conjunctival  congestion,  corneal  epithelial  edema,
middilated  unreactive  pupil,  glaucomflecken,  and  iris
atrophy; 3) 270 degree or greater of anterior chamber angle
closure on gonioscopic examination; and 4) IOP>40 mmHg
by Glodmann applanation tonometry.
The diagnostic criteria of the CPACG group were the
following: 1) the presence of glaucomatous optic neuropathy,
which was defined as a cup-to-disc ratio ≥0.7 or asymmetry
≥0.2 between the two eyes, neuroretinal rim width reduced to
≤0.1 cup-to-disc ratio, and nerve fiber layer defect; 2) visual
field  loss  detected  with  static  automated  white-on-white
threshold  perimetry  (SITA  Fast  strategy,  program  30–2,
model 750; Humphrey Field Analyzer; Carl Zeiss Meditec,
Dublin, CA) that is consistent with glaucomatous optic nerve
damage. This was established on Glaucoma Hemifield test
results  outside  normal  limits  and/or  an  abnormal  pattern
standard deviation (SD) with p<5% occurrence in the normal
population; and 3) a closed angle on indentation gonioscopy,
which was defined as the presence of at least a 180° angle in
which the posterior pigmented trabecular meshwork was not
visible and with evidence of peripheral anterior synechiae in
any part of the angle. These criteria were in compliance with
the  International  Society  for  Geographical  and
Epidemiological Ophthalmology (ISGEO) classification of
angle-closure glaucoma by Foster et al. [25].
In eyes with APACG that had a recent attack within 7
days, the IOP was controlled and the cornea without edema
were eligible for the participation of the APACG group, while
eyes  that  were  first  diagnosed  with  CPACG  and  had  not
received any systemic or topical treatment to reduce the IOP
were  eligible  for  the  CPACG  group.  The  time  interval
between the acute attack and the laser flare cell photometry
examination in the APACG eyes was 89.5±47.5 h (range
11~168 h). Eyes were excluded if they had secondary angle
closure or conditions that might influence the accuracy of
measurement or associate with impairment of the BAB such
as ocular inflammatory disease, overt cataract, retinal vein
occlusion,  retinal  detachment,  or  a  personal  history  of
hypertension, diabetes, rheumatism, or previous intraocular
surgical or laser procedures.
All  the  control  subjects  received  a  complete  ocular
examination,  which  included  best  corrected  visual  acuity
measurements using the logarithm of the minimum angle of
resolution  4-m  charts,  slit-lamp  evaluation  of  the  anterior
segment,  fundus  examination,  measurement  of  IOP,  axial
length  measurement  (A-scan  ultrasonography;  Quantel
Medical, Clermont-Ferrand, France), and detailed recording
of the health and degree of cupping of the optic nerve head.
The inclusion criteria of the control group were the following:
1) age-matched to the APACG group and CPACG group ; 2)
had open anterior chamber angles; 3) had normal optic nerve
heads with cup-to-disc ratio of ≤0.5; 4) IOPs <21 mmHg ; 5)
did not have a history of any of the aforementioned symptoms
and signs; 6) had no ophthalmic diseases except mild cataract;
7)  had  no  personal  history  of  hypertension,  diabetes,  or
rheumatism; and 8) had no previous intraocular surgical or
laser procedures. To reduce an undue contribution from a
single  patient,  if  both  eyes  were  eligible  for  the  study
participation, only the right eye served.
The quantitative measurement of aqueous flare and cells
was performed by an experienced technician, who did not
know  the  clinical  results,  with  the  use  of  laser  flare  cell
photometry (FC-2000; Kowa Co., Ltd., Tokyo, Japan). The
amount of light scattered by solutes (protein) or particles
(cells)  in  the  anterior  chamber  was  detected  by
photomultipliers in the machines. For measurement of protein
concentration (flare), the devices recorded the amount of light
detected by the photomultiplier as it was scanned across a
window measuring 0.3 mm×0.5 mm over 0.5 s, and it recorded
two background readings that were taken as the laser scans
above and below the window. The background measurements
were averaged and subtracted from the reading obtained in the
scanned  window  to  provide  a  laser  flare  photometry
measurement. For the cell count, two optical scanners were
operated  in  synchronization  to  scan  a  fixed  volume
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across a large particle (a cell) a strong peak was produced. The
number of peaks in the fixed volume was counted to give the
number  of  cells  [11].  To  ensure  the  accuracy  of  the
measurements, calibration was performed each day according
to  the  instructions  of  the  company.  For  each  eye,  seven
individual  measurements  were  obtained  in  which  the
difference between background values was 15% or less. The
highest and lowest values were discarded and the remaining
five values were averaged [26]. Flare and cell readings were
expressed as photon counts per millisecond (ph/ms) and cells/
0.5 mm3, respectively.
The data were processed and statistically analyzed using
SPSS for Windows (Version 13.0; SPSS, Chicago, IL). All
the results of age, IOP, and laser flare cell photometry were
checked for normal distribution. A χ2 test was used to compare
the  male/female  ratio.  For  comparison  between  the  two
different groups, a two-sample Student t-test was used to
evaluate differences in average between normal distributed
data  while  the  Mann–Whitney  U-test  was  used  when
abnormal distributed data existed. One-Way ANOVA was
used to compare the average among normal distributed data
in the three groups while the Kruskal–Wallis H test was used
when  abnormal  distributed  data  existed.  Spearman
correlations  analysis  was  used  for  bivariate  correlations
analysis between flare value and IOP levels, cell counts, and
IOP levels in the APACG and the CPACG groups. A p<0.05
was considered statistically significant.
RESULTS
Subjects in the APACG, CPACG, and healthy control groups:
In total, there were 35 eyes of 35 individuals in the APACG
group, 42 eyes of 42 individuals in the CPACG group, and 50
eyes  of  50  individuals  in  the  healthy  control  group,
respectively. The cases, male to female ratio, average age, and
mean IOP level of each group are summarized in Table 1.
Comparison  among  the  three  groups  did  not  reveal
significant differences in both the male/female ratio (p=0.650)
and mean age (p=0.714). The attack episode IOP level in the
APACG group, the first visit IOP level in the CPACG group
and the examination IOP level in the healthy control group
were  57.0±10.6  mmHg  (range  42~94.3  mmHg),
35.5±10.2 mmHg (range 22~62 mmHg), and 14.2±2.5 mmHg
(range 8~19 mmHg), respectively. There was a significant
difference in the mean IOP level among the three groups
(p<0.001). The APACG group had significantly higher IOP
level than CPACG group (p<0.001), while the CPACG group
had a significantly higher IOP level than the healthy control
group (p<0.001).
The anterior chamber flare value in the APACG, CPACG, and
healthy  control  groups:  The  anterior  chamber  flare  value
measured by laser flare cell photometry in the APACG group,
CPACG group, and healthy control group is showed in Table
2. The flare value was abnormally distributed in all except
healthy control group. The Kruskal–Wallis H test showed that
the difference in the flare values among the three groups was
significant  (p<0.001).  Both  the  APACG  group  and  the
CPACG group had significantly higher aqueous flare value in
the  anterior  chamber  than  that  of  healthy  control  group
(p<0.001).  Furthermore,  the  flare  value  in  the  anterior
chamber in the APACG group was significantly higher than
that in the CPACG group’s eyes according to the Mann–
Whitney U test (p<0.001).
The anterior chamber cell counts in the APACG, CPACG, and
healthy  control  groups:  The  anterior  chamber  cell  counts
measured by laser flare photometry in the APACG group,
CPACG group, and healthy control groups are showed in
Table  3.  The  cell  counts  in  the  APACG  group  were  all
abnormally  distributed.  The  cell  counts  of  3  eyes  in  the
APACG group could not be obtained. Significant differences
in the cell counts among the three groups were showed by the
Kruskal–Wallis H test (p<0.001). The cell counts either in the
APACG group or in the CPACG group were significantly
higher than those in the healthy control group. Moreover, the
cell counts in the APACG group were significantly higher
than those in the CPACG group (p<0.001).
The correlation of the IOP and flare value and the IOP and
cell counts in eyes with APACG and CPACG: The Spearman
TABLE 1. THE PARTICIPANTS’ CHARACTERISTICS.
Group APACG CPACG Healthy control p
Number of eyes 35 42 50 –
Gender (male/female) 14/21 20/22 27/27 0.650*
Age 60.7±10.1 62.2±8.8 62.5±11.0 0.714**
IOP (mmHg) 57.0±10.6 35.5±10.2 14.2±2.5 <0.001#
        The asterisk indicates the p value of the comparison among the three groups was determined by the χ2 test. The double asterisk
        indicates that the p value of the comparison among the three groups was determined by One-Way ANOVA. The sharp (hash
        mark) indicates that the p value of the comparison among the three groups was determined by the Kruskal–Wallis H test.
        Abbreviations: APACG (acute primary angle closure glaucoma), CPACG (chronic primary angle closure glaucoma), IOP
        (intraocular pressure).
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2028correlation coefficient between the IOP and flare value was
0.527 (p<0.001) and between IOP and cell counts was 0.775
(p<0.001) in eyes with APACG, while it was 0.131(p=0.408)
and  0.158  (p=0.336)  in  the  CPACG  group,  respectively
(Figure 1).
DISCUSSION
The  effective  BAB  keeps  the  aqueous  humor  almost
completely  protein  and  cell  free.  Thus,  the  emergence  of
aqueous  flare  and  cells  indicates  anterior  chamber
inflammation due to the impairment of the BAB. Artificial
grading  of  aqueous  flare  and  cells  observed  by  slit-lamp
biomicroscopy is traditionally used to evaluate the severity of
BAB  disruption  and  anterior  chamber  inflammation  [27].
However, when examined with the slit lamp, the measurement
of  intraocular  inflammation  remains  subjective  with
considerable intra- and inter-observer variations. With the use
of LFCM, we found that the flare value and cell counts in the
APACG  group  and  the  CPACG  group  were  significantly
higher than those in the age-matched healthy control group
(p<0.001). These results suggested that the BAB was impaired
and the inflammation was presented in the anterior chamber
of eyes with two kinds of PACG. LFCM demonstrated a
particular advantage in evaluating the permeability of the
BAB  and  the  inflammation  in  the  anterior  chamber  both
objectively and quantitatively in eyes with APACG. It also
allowed the detection of subclinical alterations to observe
subtle pathological changes in the BAB of eyes with CPACG.
It was reported that the BAB can be broken down by a
variety of agents such as prostaglandin and non-prostaglandin
[28].  In  addition,  the  permeability  of  the  BAB  shows  a
significant degree of pressure-dependent diffusion associated
with  transport  activity,  resembling  the  standing  gradient
osmotic flow model [29]. The effect of osmotic shock on the
BAB was investigated as early as in the 1970s [30]. However,
the effect of IOP elevation as a potential mechanical shock on
the BAB has not been studied until the present.
Because age was reported as perhaps relating to BAB
instability  [31],  and  several  medical  managements  of
glaucoma were proved to be able to affect the permeability of
BAB [23,32], eyes with APACG that had a recent attack
within  7  days  and  eyes  which  were  first  diagnosed  with
CPACG without using any systemic or topical treatment to
reduce IOP were enrolled in the PACG group in this study.
The effect of IOP elevation on the BAB was accessed by
comparing flare value and cell counts of the two PACG groups
to those of the age-matched healthy control group. Our study
showed that both the APACG group and the CPACG group
had  significantly  higher  IOP  levels  and  corresponding
significantly higher flare value and cell counts than the healthy
control  group,  implying  that  IOP  elevation  might  be
responsible for the changes of the BAB in the two PACG
groups.
Compared with the CPACG group, the inflammation in
the anterior chamber in the APACG group was more severe.
Correspondingly, the IOP level in the APACG group was
significantly higher than in the CPACG group (p<0.001). The
IOP elevation was sudden once the APACG attacked. The
speed of IOP elevation in eyes with APACG was much more
acute than in eyes with CPACG. Furthermore, the anterior
segment  ischemia  (ASI)  always  occurred  when  the  IOP
elevated  suddenly  [33].  Aung  and  his  associates  [33]
examined the iris ischemic change (IIC)—the sign of ASI—
in 61 subjects with episode of acute primary angle closure.
The results showed that more than half the subjects (52.5%)
were found to have developed IIC during the study, 65% of
TABLE 2. COMPARISON OF FLARE VALUES (PH/MS) AMONG THE APACG, CPACG, AND HEALTHY CONTROL GROUPS.
Group APACG (n=35) CPACG (n=42) Healthy control (n=50)
mean±SD 141.4±123.1 7.7±4.1 4.5±1.1
Median (interquartile range) 75.2(238.8) 6.7(4.1) 4.4(1.6)
Range 13.5~371.3 3.2~26.7 2.7~7.4
p* <0.001 <0.001 –
        The  asterisk  indicates  the  p  value  compared  with  the  healthy  control  group.  Abbreviations:  ph/ms  (photon  counts  per
        millisecond), APACG (acute primary angle closure glaucoma), CPACG (chronic primary angle closure glaucoma).
TABLE 3. COMPARISON OF THE CELL COUNTS (CELLS/0.5 MM3) AMONG THE APACG, CPACG AND HEALTHY CONTROL GROUPS.
Group APACG (n=32) CPACG (n=42) Healthy control (n=50)
mean±SD 126.0±67.8 5.2±5.8 0.8±0.7
Median (interquartile range) 111.4 (80.7) 2.8 (6.7) 1 (1.4)
Range 21.5~312.2 0~27.3 0~2.7
p* <0.001 <0.001 –
         The asterisk indicates the p value compared with the healthy control group. Abbreviations: APACG (acute primary angle closure
         glaucoma), CPACG (chronic primary angle closure glaucoma).
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2029whom already had signs of IIC by the first week. The ASI
caused the protein influx into the anterior chamber, which
aggravated  the  disruption  of  the  BAB  [34].  The  great
mechanical pressure of sudden markedly elevated IOP and the
presence  of  ASI  in  the  eyes  with  APACG  led  to  the
inflammation in the anterior chamber. Our results showed that
there were positive correlations between IOP and flare value
and cell counts in eyes with APACG, which meant that the
higher the IOP elevation, the greater the mechanical pressure,
the  more  susceptible  the  ASI,  and  the  more  severe  the
inflammation presented in eyes with APACG. However, in
eyes with CPACG, the IOP elevation was latent and mild, and
IIC was rarely found. Furthermore, the IOP level did not relate
to the mechanical pressure of the BAB directly because of the
slow speed of IOP elevation. Thus, the breakdown of the BAB
in eyes with CPACG was not as severe as that in eyes with
APACG. The IOP level did not associate with the flare value
and cell counts.
The  possibility  that  IOP  could  be  affected  by  the
increased permeability of the BAB has been reported [35,
36]. In addition, the elevated protein content, inflammatory
cells and the mediators, including cytokines and chemokines,
are considered to play an important role in the pathogenesis
of secondary elevated intraocular pressure (IOP) and uveitic
glaucoma [37,38]. However, because the systemic or topical
treatments were immediately used to reduce the IOP once
APACG was diagnosed in our study, we could not observe
any effect of increased permeability of the BAB on the IOP.
Surgical procedure is the main treatment to break the
pupillary block and control the IOP for eyes with PACG. It is
Figure 1. The relation between the IOP and flare and the IOP and cell in the APACG and CPACG group. A: The flare was positively related
with the intraocular pressure (IOP) in the acute primary angle closure glaucoma (APACG) group (r=0.527, p<0.001). B: The cell was positively
related with the IOP in the APACG group (r=0.775, p<0.001). C: There was no significant correlation between the IOP and flare in the chronic
primary angle closure glaucoma (CPACG) group (r=0.131, p=0.408). D: There was no significant correlation between the IOP and cell in the
CPACG group (r=0.158, p=0.336).
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2030reported that filtering surgery in severely inflamed eyes is
likely  to  lead  to  a  high  failure  rate  and  a  high  rate  of
complication  incidence  [39,40].  Therefore,  in  addition  to
controlling IOP, anti-inflammation treatments are necessary
for eyes with PACG, especially APACG,which can be helpful
in both improving the recovery of the BAB and increasing the
success rate of anti-glaucoma surgery.
In conclusion, our results demonstrated that the BAB was
impaired  and  inflammation  was  present  in  the  anterior
chamber in eyes with APACG and CPACG. IOP elevation is
a possible factor that causes the impairment of the BAB in
APACG. Furthermore, the ASI due to the sharp IOP elevation
may be the other risk factor that aggravates the destruction of
the BAB in APACG. The exact mechanism of the effect of
IOP and ASI on the BAB remains unclear. Attention should
be drawn to changes in the BAB in eyes with PACG.
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